全文获取类型
| 收费全文 | 2342篇 |
| 免费 | 0篇 |
专业分类
| 电工技术 | 2篇 |
| 化学工业 | 29篇 |
| 金属工艺 | 2篇 |
| 机械仪表 | 2篇 |
| 建筑科学 | 6篇 |
| 矿业工程 | 1篇 |
| 能源动力 | 6篇 |
| 轻工业 | 11篇 |
| 水利工程 | 1篇 |
| 无线电 | 12篇 |
| 一般工业技术 | 16篇 |
| 冶金工业 | 2240篇 |
| 原子能技术 | 2篇 |
| 自动化技术 | 12篇 |
出版年
| 2022年 | 1篇 |
| 2021年 | 2篇 |
| 2019年 | 5篇 |
| 2018年 | 4篇 |
| 2017年 | 1篇 |
| 2016年 | 2篇 |
| 2015年 | 1篇 |
| 2013年 | 7篇 |
| 2012年 | 5篇 |
| 2010年 | 4篇 |
| 2009年 | 7篇 |
| 2007年 | 2篇 |
| 2006年 | 4篇 |
| 2005年 | 3篇 |
| 2004年 | 1篇 |
| 2003年 | 4篇 |
| 2002年 | 3篇 |
| 2001年 | 2篇 |
| 2000年 | 4篇 |
| 1999年 | 76篇 |
| 1998年 | 721篇 |
| 1997年 | 441篇 |
| 1996年 | 253篇 |
| 1995年 | 130篇 |
| 1994年 | 101篇 |
| 1993年 | 129篇 |
| 1992年 | 19篇 |
| 1991年 | 19篇 |
| 1990年 | 17篇 |
| 1989年 | 25篇 |
| 1988年 | 34篇 |
| 1987年 | 18篇 |
| 1986年 | 15篇 |
| 1985年 | 10篇 |
| 1984年 | 3篇 |
| 1983年 | 5篇 |
| 1982年 | 9篇 |
| 1981年 | 9篇 |
| 1980年 | 17篇 |
| 1978年 | 3篇 |
| 1977年 | 62篇 |
| 1976年 | 147篇 |
| 1975年 | 5篇 |
| 1974年 | 4篇 |
| 1973年 | 2篇 |
| 1972年 | 1篇 |
| 1968年 | 1篇 |
| 1964年 | 1篇 |
| 1955年 | 3篇 |
排序方式： 共有2342条查询结果，搜索用时 0 毫秒
11.
12.
Two alkylating (cyclophosphamide and 036.5122 Asta) and two antiproliferative agents (6-mercaptopurine and azathioprine) have been compared for their immuno-suppressive potency on the primary and secondary humoral immune response of mice. If equitoxic dosages of the respective drugs are compared, the alkylating agents proved to be of much higher immunosuppressive potency than the antiproliferative agents. In non toxic dosages alkylating agents were able to completely inhibit a primary or secondary immune response, whilst a similar effect with antiproliferative drugs could not be obtained even within toxic dose ranges. Induction of immunological tolerance was possible only by use of the alkylating agents. The significance of these comparative studies is discussed in view of the frequent use of the tested drugs in clinical immunosuppression. 相似文献
13.
E Selsing AG Leslie S Arnott JG Gall DM Skinner EM Southern JH Spencer K Harbers 《Canadian Metallurgical Quarterly》1976,3(10):2451-2457
X-ray fiber diffraction studies of satellite DNAs from Gecarcinus lateralis, Drosophila virilis and Mus musculus, all of which have highly repetitious base sequences but with different degrees of sequence complexity, reveal only classical polynucleotide duplex structures in contrast to some highly repetitious synthetic DNAs. 相似文献
14.
R. Bellinghausen U. Renz 《Chemical Engineering and Processing: Process Intensification》1990,28(3):183-186
Heat transfer to fluids with pressures slightly above the critical is strongly influenced by the variation of the fluid properties occurring in the so-called pseudocritical region. The heat transfer can either be improved or reduced, depending on the flow conditions. The improvement is due to the enhanced heat transport caused by the increased heat capacity of the fluid. In the case of reduced heat transfer the turbulence is weakened by gravitational effects. In the present paper the heat transfer due to the complex interaction between gravity and turbulence in the so-called pseudocritical region is predicted by a numerical solution of the conservation equations for a turbulent pipe flow. The numerical results are compared with published experimental data for an electrically heated vertical pipe with the fluid R12. 相似文献
15.
EM van der Aa JH Peereboom-Stegeman J Noordhoek FW Gribnau FG Russel 《Canadian Metallurgical Quarterly》1998,20(4):139-148
In this review we summarized literature data on the mechanisms of human placental drug transport studied in the isolated perfused placental cotyledon, placental membrane vesicles or trophoblastic cell cultures. Overall human placental drug transport rarely exceeds the transfer of flow-dependent and membrane-limited marker compounds. Interestingly, relatively often placental drug transfer appeared to be much smaller, indicating impaired trans-placental transport, depending on the physico-chemical characteristics of the drug or placental factors such as tissue binding or metabolism. Although in perfusion studies overall human placental drug transport occurs by simple diffusion, at the membrane level several drug transport systems have been found, mainly for drugs structurally related to endogenous compounds. 相似文献
16.
The North Central Cancer Treatment Group designed a phase II trial to assess the efficacy and toxicity of topotecan in patients with unresectable malignant pleural mesothelioma. Twenty-two previously untreated patients with unresectable pleural mesothelioma and good performance status (Eastern Cooperative Oncology Group performance status 0, 1, or 2) were enrolled on this trial from October 1993 through July 1994. Nineteen men and three women, median age 66 years (range, 44-78 years), were treated with topotecan 1.5 mg/m2 intravenously over 30 minutes daily for 5 days at 3-week intervals until toxicity, progression of disease, or a patient decided to discontinue treatment. There were seven patients with measurable disease and 15 with evaluable disease; all were assessable for response and toxicity. A total of 113 cycles of treatment were given, for a median of three cycles (range, 1-26 cycles). Myelosuppression was the most frequent toxicity. Eighteen of 21 patients (86%) experienced grade 3 or 4 neutropenia during the initial treatment cycle. The median neutrophil nadir was 0.5 x 10(3)/microl (range, 0.1-1.6 x 10(3)/microl), and the median platelet nadir was 127 x 10(3)/microl (range, 18-460 x 10(3)/microl). Other toxicities more than grade 2 included malaise (two patients), and anorexia, infection, fever, pulmonary, and cardiac in one patient each. There were no objective responses, and 18 patients had stable disease for a median of 74 days. The median survival for all patients was 230 days, with 23% alive at 1 year. Topotecan as administered in this trial is reasonably well tolerated; however, the response rate was insufficient to warrant additional study in pleural mesothelioma. 相似文献
17.
18.
KW Mahaffey CB Granger R Collins CM O'Connor EM Ohman SD Bleich JJ Col RM Califf 《Canadian Metallurgical Quarterly》1996,77(8):551-556
Intravenous heparin is routinely given after thrombolytic therapy for patients with acute myocardial infarction in the United States and in some, but by no means all, other countries. Several trials have documented improved infarct-artery patency in patients treated with heparin; however, none was large enough individually to assess the effect of heparin on clinical outcomes. We performed a systematic overview of the 6 randomized controlled trials (1,735 patients) to summarize the available data concerning the risks and benefits of intravenous heparin versus no heparin after thrombolytic therapy. Mortality before hospital discharge was 5.1% for patients allocated to intravenous heparin compared with 5.6% for controls (relative risk reduction of 9%, odds ratio 0.91, 95% confidence interval 0.59 to 1.39). Similar rates of recurrent ischemia and reinfarction were observed among those allocated to heparin therapy or control. The rates of total stroke, intracranial hemorrhage, and severe bleeding were similar in patients allocated to heparin; however, the risk of any severity of bleeding was significantly higher (22.7% vs 16.2%; odds ratio 1.55, 95% confidence interval 1.21 to 1.98). There was no significant difference in the observed effects of heparin between patients receiving tissue-type plasminogen activator and those receiving streptokinase or anisoylated plasminogen streptokinase activator complex, or between patients who did and did not receive aspirin. The findings of this overview demonstrate that insufficient clinical outcome data are available to support or to refute the routine use of intravenous heparin therapy after thrombolysis. It is not known if these findings are due to lack of statistical power, inappropriate levels of anticoagulation, or lack of benefit of intravenous heparin. Large randomized studies of heparin (and of new antithrombotic regimens) are needed to establish the role of such therapy. 相似文献
19.
The purpose of this study was to determine the acute effects of doxorubicin and its less cardiotoxic epimer, 4'-epirubicin, on the contractile response of isolated myocytes, and to assess similarities or differences with respect to active oxygen-derived mechanisms. Calcium-tolerant myocytes from rat ventricle were field stimulated at 1.0 Hz, and the maximum extent of cell shortening, peak shortening velocity, and peak relaxation velocity of single twitches were measured by video edge detection. The contractile responses of the myocytes to the two anthracyclines were approximately equal. Exposure of the cells to 10 microM of either anthracycline for 20 min decreased all indices of contractility by 28% (p < 0.05). The active oxygen scavengers, superoxide dismutase and catalase, distinguished the extent to which active oxygen was involved in modifying cellular contractility. Paradoxically, superoxide dismutase alone (10 U/mL) decreased contractility by 21%. Nevertheless, superoxide dismutase (10 U/mL) prevented the decreases in contractility produced by doxorubicin. In contrast, superoxide dismutase only mildly (32%) protected against 4'-epirubicin. Catalase (10 U/mL), however, provided substantial (82-93%) protection against both anthracyclines. Hydrogen peroxide therefore, and presumably hydroxyl radicals, were involved in mediating the decreases in contractility from both doxorubicin and 4'-epirubicin. These results show that an acute exposure to clinically relevant concentrations of these anthracyclines significantly depresses myocyte contractility and that, in this respect, 4'-epirubicin is as potentially cardiotoxic as doxorubicin. The results with antioxidant enzymes also strongly support a free radical mechanism for the toxicity of doxorubicin and 4'-epirubicin to cardiomyocytes. 相似文献
20.